Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Put Your School on the Map
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Put Your School on the Map
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Emerging Therapy
Page 19
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Aravax Testing New Way to Tackle Food Allergy
News Wire ~ 3rd Party Press Release
-
2024/11/15
Are Biologics the Future of Food Allergy Treatment? One Study Weighs Pros and Cons
Aquestive Announces Positive Topline Results from Study of Sublingual Epinephrine Film on OAS
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
New Phase 1 Study in Peanut Allergy Recruiting Now in Australia
US FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut...
News Wire ~ 3rd Party Press Release
-
2019/03/18
0
Update on Delivery of Emergency Epinephrine via Sublingual Film
Dave Bloom
-
2019/03/14
0
FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents
News Wire ~ 3rd Party Press Release
-
2019/03/12
0
Aimmune Therapeutics Presents New AR101 Data Including Demonstrated Reduction in Accidental...
News Wire ~ 3rd Party Press Release
-
2019/02/25
0
FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray
News Wire ~ 3rd Party Press Release
-
2019/02/19
0
Study: Treatment with Omalizumab Raises Tolerance in Patients with Severe Food...
Dave Bloom
-
2019/02/15
0
DBV to Resubmit Application to FDA for Viaskin Peanut Approval in...
News Wire ~ 3rd Party Press Release
-
2019/02/14
0
Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate
Dave Bloom
-
2019/01/16
0
Company Developing Microbiome-Derived Food Allergy Therapy Raises $27 Million
Dave Bloom
-
2018/12/28
0
Aimmune Submits FDA Application to Offer AR101 for the Treatment of...
News Wire ~ 3rd Party Press Release
-
2018/12/21
0
1
...
18
19
20
...
27
Page 19 of 27